Matches in Nanopublications for { ?s ?p "[Our study demonstrated synergistic antitumor activity of combined VEGF shRNA expressing plasmids and low-dose DDP with no overt toxicity, suggesting potential applications of the combined approach in the treatment of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP184046.RAa5x6qQ2UuGcYXZGiQsjkbtXsz_5hdCeCcJn4nVR9V1o130_assertion description "[Our study demonstrated synergistic antitumor activity of combined VEGF shRNA expressing plasmids and low-dose DDP with no overt toxicity, suggesting potential applications of the combined approach in the treatment of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184046.RAa5x6qQ2UuGcYXZGiQsjkbtXsz_5hdCeCcJn4nVR9V1o130_provenance.
- NP344236.RAhRv35nbV5gw6gfR9iutZURaK57nN6XOD_vBOo4b8Y3I130_assertion description "[Our study demonstrated synergistic antitumor activity of combined VEGF shRNA expressing plasmids and low-dose DDP with no overt toxicity, suggesting potential applications of the combined approach in the treatment of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344236.RAhRv35nbV5gw6gfR9iutZURaK57nN6XOD_vBOo4b8Y3I130_provenance.
- NP801859.RAkE5FYTDtxvVbwC2krglvhbCJXSV5SJhW50Su7HFLu3k130_assertion description "[Our study demonstrated synergistic antitumor activity of combined VEGF shRNA expressing plasmids and low-dose DDP with no overt toxicity, suggesting potential applications of the combined approach in the treatment of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801859.RAkE5FYTDtxvVbwC2krglvhbCJXSV5SJhW50Su7HFLu3k130_provenance.
- NP814194.RAckxrhPn4qy0A4vC_yXcOFlUNeKKwsvFlaOQBmKDHwVY130_assertion description "[Our study demonstrated synergistic antitumor activity of combined VEGF shRNA expressing plasmids and low-dose DDP with no overt toxicity, suggesting potential applications of the combined approach in the treatment of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814194.RAckxrhPn4qy0A4vC_yXcOFlUNeKKwsvFlaOQBmKDHwVY130_provenance.
- NP353050.RAmjxx_MjM_DbYzBgihSIZZ9ZoIH-s95klQPGNK7kAAa8130_assertion description "[Our study demonstrated synergistic antitumor activity of combined VEGF shRNA expressing plasmids and low-dose DDP with no overt toxicity, suggesting potential applications of the combined approach in the treatment of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353050.RAmjxx_MjM_DbYzBgihSIZZ9ZoIH-s95klQPGNK7kAAa8130_provenance.
- NP814191.RApzF5KPkBTTO9Y3XWZwRSH_Iy7RLVdCQsXZHazcYZBms130_assertion description "[Our study demonstrated synergistic antitumor activity of combined VEGF shRNA expressing plasmids and low-dose DDP with no overt toxicity, suggesting potential applications of the combined approach in the treatment of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814191.RApzF5KPkBTTO9Y3XWZwRSH_Iy7RLVdCQsXZHazcYZBms130_provenance.
- NP353075.RAOOMy1TJGr2VK0WhWavjRpRUdwVSjC84WHxHbJoWq3MY130_assertion description "[Our study demonstrated synergistic antitumor activity of combined VEGF shRNA expressing plasmids and low-dose DDP with no overt toxicity, suggesting potential applications of the combined approach in the treatment of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353075.RAOOMy1TJGr2VK0WhWavjRpRUdwVSjC84WHxHbJoWq3MY130_provenance.
- NP814193.RAIlf7_Tnbec9LogPmf2feVGTo0iPuokIoAp2xQVjkmWw130_assertion description "[Our study demonstrated synergistic antitumor activity of combined VEGF shRNA expressing plasmids and low-dose DDP with no overt toxicity, suggesting potential applications of the combined approach in the treatment of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814193.RAIlf7_Tnbec9LogPmf2feVGTo0iPuokIoAp2xQVjkmWw130_provenance.
- NP814192.RA6Xd4B2CYsrJZt-8pq9nCX3cb8vuZyh7zPG6eT_8FdqQ130_assertion description "[Our study demonstrated synergistic antitumor activity of combined VEGF shRNA expressing plasmids and low-dose DDP with no overt toxicity, suggesting potential applications of the combined approach in the treatment of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814192.RA6Xd4B2CYsrJZt-8pq9nCX3cb8vuZyh7zPG6eT_8FdqQ130_provenance.